Recent Finacing
Recent Raise
Tolero Pharmaceuticals is a clinical-stage biopharma developing CDK inhibitor alvocidib as a front-line combination therapy for AML and relapsed/refractory AML, while advancing preclinical programs for blood disorders.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors